The present study aims to assess secretagogin as a potential soluble biomarker of human islets stress by using translational in vivo and in vitro models and determining the secretagogin level in plasma samples from diabetes patients compared with healthy controls. This evidence concerns the gene SCGN and diabetes mellitus.